Differentiation Stage-Specific Inhibition of the Raf-MEK-ERK Pathway by Akt

Christian Rommel(Regeneron (United States)), Brian Clarke(Regeneron (United States)), Sven Zimmermann(University of Zurich), Lorna Nuñez(Regeneron (United States)), Roni Rossman(Regeneron (United States)), Kristina Reid(Regeneron (United States)), Karin Moelling(University of Zurich), George D. Yancopoulos(Regeneron (United States)), David J. Glass(Regeneron (United States))
Science
November 26, 1999
Cited by 768

Abstract

Extracellular signals often result in simultaneous activation of both the Raf-MEK-ERK and PI3K-Akt pathways (where ERK is extracellular-regulated kinase, MEK is mitogen-activated protein kinase or ERK kinase, and PI3K is phosphatidylinositol 3-kinase). However, these two signaling pathways were shown to exert opposing effects on muscle cell hypertrophy. Furthermore, the PI3K-Akt pathway was shown to inhibit the Raf-MEK-ERK pathway; this cross-regulation depended on the differentiation state of the cell: Akt activation inhibited the Raf-MEK-ERK pathway in differentiated myotubes, but not in their myoblast precursors. The stage-specific inhibitory action of Akt correlated with its stage-specific ability to form a complex with Raf, suggesting the existence of differentially expressed mediators of an inhibitory Akt-Raf complex.


Related Papers

No related papers found

Powered by citation graph analysis